Imlunestrant (LY-3484356) is an orally active, selective estrogen receptor degrader that persistently inhibits ER-dependent gene transcription and cell growth. It is suitable for investigating ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.
Molecular Weight:
524.51
Purity:
97.35%
CAS Number:
[2408840-26-4]
Formula:
C29H24F4N2O3
Target:
Estrogen Receptor/ERR
T63674
* VAT and and shipping costs not included. Errors and price changes excepted